DICER1 and melanoma: Of the 32 TCGA tumors with germline DICER1 variation we analyzed (Table S1), four (testicular, breast, and prostate cancers and melanoma) have been reported in cohorts with germline DICER1 pathogenic variation (DICER1‐carriers).